Cite

HARVARD Citation

    Emran, A. et al. (2019). Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy. Trends in immunology. 40 (4), pp. 328-344. [Online]. 
  
Back to record